Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

January 10, 2022

Primary Completion Date

July 30, 2024

Study Completion Date

July 30, 2024

Conditions
E-Cig Use
Interventions
DRUG

Tobacco flavored liquid type 1

A commercially available cartridge-based device with tobacco flavored liquid.

DRUG

Tobacco flavored liquid type 2

A commercially available cartridge-based device with tobacco flavored liquid.

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT05199480 - Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health | Biotech Hunter | Biotech Hunter